Abstract:Objective: This study assessed the cardioprotective properties of Persicaria maculosa (PME) and Citrus sinensis (CME) hydro-methanolic extracts, besides Citrus sinensis aqueous extract (CWE) against doxorubicin (DOX)-induced cardiotoxicity. Materials and methods: The extracts were characterized. Mice were divided into eight groups: control (saline), DOX, protected (injected with 200 mg/kg of PME, CWE or CME for 21 days, orally, and DOX), and extracts (PME, CWE or CME administration, orally, for 21 days). DOX was injected (5 mg/kg, ip) on days 8, 13 and 18 of the experiment. Cardiac tumor necrosis factor-alpha (TNF-α), nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and carbonyl reductase 1 (CBR1) expression levels, besides superoxide dismutase, catalase, malondialdehyde, nitric oxide and total protein levels were evaluated. Serum lactate dehydrogenase, creatine phosphokinase cardiac isoenzyme, aspartate transaminase, cholesterol, triglycerides and creatinine levels, as well as the cardiac tissues were examined. Results: Comparing with the control, DOX considerably (p<0.01) up-regulated TNF-α expression, malondialdehyde, nitric oxide, cardiac enzymes, lipids and creatinine levels, while it significantly (p<0.01) down-regulated Nrf2 and CBR1. Additionally, DOX interfered with antioxidant enzymes' activities (p<0.01). Conversely, protected groups showed a significant (p<0.01) amelioration of DOX-induced cardiotoxic effects. Conclusion: The current study provides a new understanding of P. maculosa and C. sinensis cardioprotective mechanisms. The extracts' cardioprotective effects may be due to their antioxidant activities, ability to maintain the redox homeostasis through regulation of important antioxidant genes and primary antioxidant enzymes, and capability to recover inflammatory cytokines and lipids levels. Noteworthy, the tested extracts showed no toxic changes on the normal mice.

Phenolic constituents from the root bark of Morus alba L. and their cardioprotective activity in vitro

Bioassay-guided screening and isolation of α-glucosidase and tyrosinase inhibitors from leaves of Morus alba

Compounds Inhibiting Hyperglycemia and Cancer Cell Proliferation from Morus Alba L

In vivo hypoglycemic effects of phenolics from the root bark of Morus alba

Two Novel Compounds from the Root Bark of Morus Alba L.

The Research on Chemical Ingredients of the Heartwood of Root of Morus atpropurpurea

Isoprenylated Flavonoids and 2-Arylbenzofurans from the Root Bark of Morus alba L. and Their Cytotoxic Activity against HGC27 Cancer Cells

A New Flavanone Glycoside with Anti-proliferation Activity from the Root Bark of Morus Alba

Extraction, derivatization, and antioxidant activity of Morinda citrifolia polysaccharide

α-Glucosidase inhibitors and antioxidants from root bark of Morus alba

Prenylated Dihydroflavones from the Root Barks of Morus Alba

The cardioprotective properties of Persicaria maculosa and Citrus sinensis extracts against doxorubicin-induced cardiotoxicity in mice

Isolation, characterization and biological activities of phenolics from the roots bark of Morus alba

Three New Compounds from Morus Nigra L.

Simultaneous Characterization and Quantification of Flavonoids in Morus Australis Root As Potential Hepatoprotective Nutraceutical.

Pharmacokinetics and molecular docking of the cardioprotective flavonoids in Dalbergia odorifera

Characterization of a New Flavone and Tyrosinase Inhibition Constituents from the Twigs of Morus alba L.

Chemical Constituents from Morus Notabilis and Their Cytotoxic Effect

Hypoxia-inducible factor-1 inhibitory benzofurans and chalcone-derived diels-alder adducts from Morus species.

Antioxidant Compounds from Twig of Morus Alba

Bioactive flavonoids and stilbenes from the leaf of Morus alba var. multicaulis